Home › Blood Cancers › NCT03023202
UWCCC Molecular Tumor Board Registry
RecruitingObservational study
UWCCC Precision Medicine Molecular Tumor Board Registry
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Clinically suspected or histologically confirmed solid or hematological malignancy * Undergoing genetic testing of tumor * Ability to understand written informed consent document * Willingness to sign written informed consent document Exclusion Criteria: * Pediatric patients (age\<18 years) will be excluded due to a lack of expertise on the molecular tumor committee
About the study
This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.
What is being tested
- PMMTB (Precision Medicine Molecular Tumor Board) (other)
Sponsor: University of Wisconsin, Madison · Participants: 10,000 · Started: Mar 30, 2016
Contact the study team
- Cancer Connect · Phone: 8006228922
Official record on ClinicalTrials.gov — NCT03023202
Locations in the U.S.
| Wisconsin | University of Wisconsin Carbone Cancer Center, Madison |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.